A
RMD icon

AustralianSuper’s ResMed RMD Stock Holding History

AustralianSuper’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.6M Buy
434,614
+25,748
+6% +$6.42M 0.51% 58
2025
Q4 		$98.5M Buy
408,866
+51,381
+14% +$13.1M 0.46% 47
2025
Q3 		$97.9M Buy
357,485
+46,079
+15% +$12.6M 0.46% 51
2025
Q2 		$80.3M Buy
311,406
+41,226
+15% +$9.83M 0.41% 60
2025
Q1 		$60.5M Buy
270,180
+166,257
+160% +$38.8M 0.34% 82
2024
Q4 		$23.8M Buy
103,923
+100,836
+3,266% +$24.3M 0.11% 114
2024
Q3 		$754K Hold
3,087
– – ﹤0.01% 219
2024
Q2 		$591K Buy
+3,087
New +$626K ﹤0.01% 215

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AustralianSuper's RMD Position: Q1 2026 in Review

AustralianSuper increased its ResMed (RMD) stake by 6.3% in Q1 2026, buying an estimated $6.42M and bringing the position to 434,614 shares worth $97.6M. The position accounts for 0.51% of the portfolio, ranked #58.

AustralianSuper first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $98.5M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • AustralianSuper held 434,614 shares of ResMed worth $97.6M as of Q1 2026.
  • AustralianSuper bought 25,748 ResMed shares in Q1 2026, an estimated $6.42M.
  • ResMed made up 0.51% of AustralianSuper's portfolio in Q1 2026, its #58 holding.
  • AustralianSuper first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • AustralianSuper's ResMed position peaked at $98.5M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.